Growth Metrics

Ingevity (NGVT) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Ingevity (NGVT) over the last 11 years, with Q3 2025 value amounting to $1.8 billion.

  • Ingevity's Liabilities and Shareholders Equity fell 1708.27% to $1.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.8 billion, marking a year-over-year decrease of 1950.61%. This contributed to the annual value of $2.0 billion for FY2024, which is 2289.86% down from last year.
  • According to the latest figures from Q3 2025, Ingevity's Liabilities and Shareholders Equity is $1.8 billion, which was down 1708.27% from $1.9 billion recorded in Q2 2025.
  • Over the past 5 years, Ingevity's Liabilities and Shareholders Equity peaked at $2.8 billion during Q2 2023, and registered a low of $1.8 billion during Q3 2025.
  • Over the past 5 years, Ingevity's median Liabilities and Shareholders Equity value was $2.4 billion (recorded in 2021), while the average stood at $2.4 billion.
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first skyrocketed by 1953.93% in 2023, then plummeted by 2289.86% in 2024.
  • Ingevity's Liabilities and Shareholders Equity (Quarter) stood at $2.5 billion in 2021, then grew by 10.83% to $2.7 billion in 2022, then decreased by 4.14% to $2.6 billion in 2023, then fell by 22.9% to $2.0 billion in 2024, then fell by 9.33% to $1.8 billion in 2025.
  • Its last three reported values are $1.8 billion in Q3 2025, $1.9 billion for Q2 2025, and $2.1 billion during Q1 2025.